SAR447754
/ Sanofi
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 13, 2026
SAD18615-MAD18616: A Phase 1 first-in-human study to evaluate SAR447754 in healthy adult participants and in adult participants with moderate-to-severe atopic dermatitis.
(clinicaltrialsregister.eu)
- P1 | N=207 | Recruiting | Sponsor: Sanofi-Aventis Recherche & Developpement | Not yet recruiting ➔ Recruiting
Enrollment open • First-in-human • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
1 to 1
Of
1
Go to page
1